Artículos Científicos

A short, animated video to improve good COVID-19 hygiene practices: a structured summary of a study protocol for a randomized controlled trial

The present study is a multi-site, parallel group, randomized controlled trial (RCT)

COVID-19: ¿es la cuarentena una medida efectiva para evitar la diseminación y los fallecimientos?

La enfermedad por el nuevo coronavirus del año 2019 (COVID-19)

False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications

There is broad consensus that widespread SARS-CoV-2 testing is essential to safely reopening the United States.

Our Italian experience using lung ultrasound for identification, grading and serial follow-up of severity of lung involvement for management of patients with COVID-19

During this ongoing battle against the novel COVID-19

SARS-CoV-2 Vaccines: Status Report

SARS-CoV-2, the causal agent of COVID-19, first emerged in late 2019 in China.

The epidemiology and clinical information about COVID-19

At the end of 2019, several cases of pneumonia with unknown etiology emerged inWuhan, Hubei Province, China

The term ‘physical distancing’ is recommended rather than ‘social distancing’ during the COVID-19 pandemic for reducing feelings of rejection among people with mental health problems

As COVID-19 has plagued our world, the term “social distancing” has been widely used with the aim to encourage

Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis

SARS-CoV-2 might spread through aerosols from respiratory droplets;

Physical distancing, face masks, and eye protection for prevention of COVID-19

The choice of various respiratory protection mechanisms, including face masks and respirators, has been a vexed issue

Covid-19: Physical distancing of at least one metre is linked to large reduction in infection

Physical distancing of at least a metre is associated with a “large reduction” in covid-19 infection

COVID-19-Guías

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial

French Confirmed COVID-19 patients were included in a single arm protocol from early March to March 16th

Boletín sobre COVID-19

Salud Pública y Epidemiología

Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Hydroxychloroquine or chloroquine, often in combination with a second-generation macrolide, are being widely used for treatment of COVID-19

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Preventing suicide in the context of the COVID-19 pandemic

The impact of the COVID-19 pandemic on the labour market, as well as the government’s response to mitigate risk via social isolation and quarantine

Principles of mental health care during the COVID-19 pandemic

The World Health Organization (WHO) developed following a series of events, with the first one of them being the international sanitary conference (in 1851)

Suicide among physicians and health-care workers: A systematic review and metaanalysis

Suicide risk was increased in certain occupational groups, especially in medical-related professions [

Suicide in the Time of COVID-19: A Perfect Storm

Suicide is a leading cause of death in the United States and Kentucky. In the US, suicide rates have steadily risen over the past 2 decades by an estimated 30%.

SuicideMortality and Coronavirus Disease 2019— A Perfect Storm?

Suicide rates have been rising in the US over the last 2 decades.

Surgical Considerations in Patients with COVID-19

COVID-19 is now established in all but a handful of small countries

COVID-19 Testing: The Threat of False-Negative Results

As health care systems around the world attempt to cope with the coronavirus disease 2019 (COVID- 19)

SAGES and EAES recommendations for minimally invasive surgery during COVID‑19 pandemic

The unprecedented pandemic of COVID-19 has impacted many lives and affects the whole healthcare systems globally

Perioperative Considerations in Urgent Surgical Care of Suspected and Confirmed Coronavirus

Perioperative Considerations During Emergency General Surgery in the Era of COVID-19: A U.S. Experience

The novel coronavirus SARS-CoV-2 (COVID-19) strain was initially identified in China in early December 2019.

Geospatial Mapping of Orthopaedic Surgeons Age 60 and Over and Confirmed Cases of COVID-19

Coronavirus disease 2019 (COVID-19) presents unique challenges to the orthopaedic workforce within the U.S.

European Society of Trauma and Emergency Surgery (ESTES) recommendations for trauma and emergency surgery preparation during times of COVID‑19 infection

Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19)

The novel coronavirus disease 2019 (COVID-19) outbreak is an ongoing situation caused

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Repositioning of drugs for use as antiviral treatments is a critical need.

No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection

Risk-of-QT-Interval-Prolongation-Associated-With-Use

As of April 10, 2020, more than 500000 cases of coronavirus disease 2019 (COVID-19) have been reported in the United States

The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19—First, Do No Harm

On March 21, 2020, President Donald Trump tweeted that hydroxychloroquine and azithromycin

COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

What Is the Evidence?

Training and Fit Testing of Health Care Personnel for Reusable Elastomeric Half-Mask Respirators ComparedWith Disposable N95 Respirators

The demand for disposable respiratory protective devices needed to protect health care personnel may exceed supply during large outbreaks of respiratory infectious diseases.

Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence

The novel coronavirus 2019 (2019-nCoV), officially named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Remdesivir as a possible therapeutic option for the COVID-19

In a recent review article, there were multiple preventive measures that were proposed for the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Infectious Diseases Society of America Guidelines on Infection Prevention for Health Care Personnel Caring for Patients with Suspected or Known COVID-19

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Since the first cases were reported in December 2019, infection with the severe acute respiratory coronavirus 2 (SARS-CoV-2) has become a worldwide pandemic

Antiviral treatment of COVID-19

Currently, there is not any specific effective antiviral treatment for COVID-19.

Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient

Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

The ongoing COVID-19 outbreak has spread rapidly on a global scale. While the transmission of SARS-CoV-2

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

The ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Protected Code Stroke

Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic

Proceso de Prevención de Infecciones para las personas con Covid-19 (enfermedad por SARSCoV- 2)

Contactos y personal de la salud

Preparing for theMost Critically Ill PatientsWith COVID-19

The Potential Role of Extracorporeal Membrane Oxygenation

Guía técnica de prevención y control de infecciones durante la atención sanitaria de casos sospechosos o confirmados de Covid-19

Manejo de cadáveres ante la sospecha o confirmación de infección por COVID-19

Barrier Enclosure during Endotracheal Intubation

Clinicians with inadequate access to standard personal protective equipment (PPE) have been compelled to improvise protective barrier enclosures for use during endotracheal intubation.

Characterization of antibiotic resistance and host-microbiome interactions in the human upper respiratory tract during influenza infection

Influenza virus infection is commonly followed by secondary bacterial infection

Using the spike protein feature to predict infection risk and monitor the evolutionary dynamic of coronavirus

oronavirus (CoV) belongs to the order Nidovirales and can infect humans, mammals, and birds

An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China

Community Prevalence of SARS-CoV-2 Among PatientsWith Influenzalike Illnesses Presenting to a Los Angeles Medical Center in March 2020

Coronavirus Disease 2019 and Children What Pediatric Health Care Clinicians Need to Know

The emergence of a coronavirus illness not previously seen in humans, now called coronavirus disease 2019 (COVID-19),

Treatment of 5 Critically Ill Patients WithCOVID-19 With Convalescent Plasma

The epidemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Massachusetts General Hospital COVID-19 Treatment Guidance

This document was prepared (in March/April, 2020) by and for MGH medical professionals (a.k.a. clinicians, care givers)

Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

At the end of 2019, a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 inWuhan, China

SinceDecember 2019, coronavirus disease 2019 (COVID- 19)

Información Relevante sobre la Perspectiva Ética ante Epidemias en el Contexto del Covid-19

Lineamientos Generales

Emergencia Sanitaria del Covid-19

El Instituto de Investigaciones Jurídicas de la Universidad Nacional Autónoma de México (IIJ-UNAM), se constituye, por sí mismo, además de la labor propia de investigación, docencia y vinculación...

Developing Covid-19 Vaccines at Pandemic Speed

The need to rapidly develop a vaccine against SARS-CoV-2 comes at a time of explosion in basic scientific understanding, including in areas such as genomics and structural biology

Mental Health Strategies to Combat the Psychological Impact of COVID-19 Beyond Paranoia and Panic

The coronavirus disease 2019 (COVID-19) outbreak was declared a public health emergency of international concern by the World Health Organization (WHO)

Treating COVID-19—Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics

In the 2014 Ebola outbreak, close to30 000individuals developed Ebola viral disease (EVD)

SARS-CoV-2 Transmission in PatientsWith Cancer at a Tertiary Care Hospital inWuhan, China

In December 2019, an outbreak of 2019 novel coronavirus disease (COVID-19)

Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed

The 2019 novel coronavirus (2019-nCoV) pneumonia, believed to have originated in a wet market in Wuhan, Hubei province, China at the end of 2019

The emotional impact of Coronavirus 2019-nCoV (new Coronavirus disease)

The emergence of a novel form of Coronavirus (2019-nCoV) in Wuhan has created a confused and rapidly evolving situation.

What does the future hold for doctors and suicide?

Physician suicide is topic of growing professional and public health concern.

Mental health and psychosocial considerations during the COVID-19 outbreak

In January 2020 the World Health Organization (WHO) declared the outbreak of a new coronavirus disease, COVID-19, to be a Public Health Emergency of International Concern.